We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-14.14%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$360M
AUM Growth
-$46.9M
Cap. Flow
-$5.57M
Cap. Flow %
-1.55%
Top 10 Hldgs %
13.59%
Holding
339
New
120
Increased
41
Reduced
71
Closed
90

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$6.24M
2
ADBE icon
Adobe
ADBE
+$5.65M
3
NVDA icon
NVIDIA
NVDA
+$5.46M
4
EA icon
Electronic Arts
EA
+$5.33M
5
GS icon
Goldman Sachs
GS
+$5.21M

Top Sells

Rank Stock Value
1
QLYS icon
Qualys
QLYS
+$10.4M
2
HDP
Hortonworks, Inc.
HDP
+$9.34M
3
CW icon
Curtiss-Wright
CW
+$7.91M
4
ADAP
Adaptimmune Therapeutics
ADAP
+$7.67M
5
XLRN
Acceleron Pharma
XLRN
+$7.16M

Sector Composition

Rank Sector Weight
1 Technology 17.65%
2 Industrials 15.24%
3 Healthcare 12.96%
4 Consumer Discretionary 6.56%
5 Financials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
51
Boeing
BA
$165B
$1.91M 0.53%
5,921
-728
-11% -$252K
TFC icon
52
Truist Financial
TFC
$63.2B
$1.91M 0.53%
44,098
-3,894
-8% -$187K
RTX icon
53
RTX Corp
RTX
$287B
$1.9M 0.53%
28,386
-5,045
-15% -$396K
CCI icon
54
Crown Castle
CCI
$32.7B
$1.9M 0.53%
17,499
-2,066
-11% -$227K
SPG icon
55
Simon Property Group
SPG
$74.5B
$1.86M 0.52%
11,071
-990
-8% -$177K
AKBA icon
56
Akebia Therapeutics
AKBA
$327M
$1.85M 0.51%
334,328
+33,146
+11% +$259K
ABBV icon
57
AbbVie
ABBV
$458B
$1.76M 0.49%
19,148
-1,426
-7% -$125K
SNY icon
58
Sanofi
SNY
$104B
$1.71M 0.47%
39,364
-3,001
-7% -$132K
GILD icon
59
Gilead Sciences
GILD
$161B
$1.67M 0.46%
26,763
-2,670
-9% -$187K
DUK icon
60
Duke Energy
DUK
$102B
$1.64M 0.45%
18,968
-2,265
-11% -$193K
EQR icon
61
Equity Residential
EQR
$25.4B
$1.55M 0.43%
23,523
-3,249
-12% -$218K
BXMT icon
62
Blackstone Mortgage Trust
BXMT
$2.82B
$1.52M 0.42%
47,772
-7,386
-13% -$250K
LMT icon
63
Lockheed Martin
LMT
$134B
$1.48M 0.41%
5,657
+886
+19% +$269K
CVS icon
64
CVS Health
CVS
$137B
$1.47M 0.41%
22,372
-2,723
-11% -$203K
LYB icon
65
LyondellBasell Industries
LYB
$19.5B
$1.43M 0.4%
17,153
-917
-5% -$83.9K
PH icon
66
Parker-Hannifin
PH
$125B
$1.39M 0.39%
9,316
-8
-0.1% -$1.29K
GOOGL icon
67
Alphabet (Google) Class A
GOOGL
$3.91T
$1.37M 0.38%
26,260
+4,980
+23% +$269K
SAFT icon
68
Safety Insurance
SAFT
$1.52B
$1.37M 0.38%
16,693
-2,594
-13% -$221K
NEE icon
69
NextEra Energy
NEE
$187B
$1.36M 0.38%
31,404
+796
+3% +$34.8K
MIME
70
DELISTED
Mimecast Limited
MIME
$1.36M 0.38%
+40,527
New +$1.41M
UNH icon
71
UnitedHealth
UNH
$382B
$1.35M 0.37%
5,404
-308
-5% -$81.4K
HBAN icon
72
Huntington Bancshares
HBAN
$35.1B
$1.32M 0.37%
110,507
-19,621
-15% -$272K
SLP icon
73
Simulations Plus
SLP
$371M
$1.25M 0.35%
63,024
-7,589
-11% -$150K
T icon
74
AT&T
T
$165B
$1.23M 0.34%
57,132
-4,343
-7% -$101K
KEY icon
75
KeyCorp
KEY
$24.3B
$1.23M 0.34%
83,200
-16,722
-17% -$294K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2018 Portfolio in Review

As of Q4 2018, Stanley-Laman Group held 339 positions worth $360M, down 12% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Stanley-Laman Group's Q4 2018 filing shows 120 new, 41 increased, 71 reduced and 90 closed positions. Its largest new stake was New Relic, Inc.: 74,133 shares worth $6M. The largest sale was Qualys, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2018 buy was New Relic, Inc.: 74,133 shares worth $6M.
  • Stanley-Laman Group added most to Raytheon Company in Q4 2018, an estimated $4.87M increase.
  • Stanley-Laman Group's biggest Q4 2018 reduction was Tiffany & Co., cutting an estimated $1.02M.
  • Stanley-Laman Group fully exited Qualys in Q4 2018, selling an estimated $10.4M.
  • Stanley-Laman Group's ten largest holdings make up 14% of its $360M portfolio in Q4 2018.
  • Stanley-Laman Group opened 120 new positions and closed 90 in Q4 2018.
  • Stanley-Laman Group's portfolio value fell 12% quarter-over-quarter to $360M.

Based on Stanley-Laman Group's 13F filing for Q4 2018, filed 7 Feb 2019.